Ishida, C. T. (2018). Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationIshida, C. T. Metabolic Reprogramming by Dual AKT/ERK Inhibition Through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationIshida, C. T. Metabolic Reprogramming by Dual AKT/ERK Inhibition Through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.